Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-08-31 El-Hibri Fuad Chairman Sale −5,461 $37.50 $205K 1,624,755
2017-08-15 Hauer Jerome M Director Grant or award +5,153 $25.47 $131K 29,421
2017-08-15 Hauer Jerome M Director Sale −10,776 $35.83 $386K 18,645
2017-08-15 Hauer Jerome M Director Exercise or conversion · Stock Option (Right to Buy) −5,153 5,152
2017-08-08 SARAN ATUL EVP, Corp Dev, GC & Secretary Grant or award +12,814 12,814
2017-08-08 SARAN ATUL EVP, Corp Dev, GC & Secretary Grant or award · Employee stock option (right to buy) +20,083 20,083
2017-07-27 El-Hibri Fuad Chairman Sale −25,000 $36.50 $913K 1,630,216

Page 45 of 45 · 887 trades